{rfName}

Indexed in

License and use

Altmetrics

Analysis of institutional authors

Cuatrecasas, MAuthorMoreira, LAuthor

Share

January 3, 2024
Publications
>
Editorial Material
No

History and clinical guidelines for chronic atrophic gastritis and the assessment of gastric cancer risk

Publicated to:Gastroenterologia Y Hepatologia. 46 (9): 727-731 - 2023-11-01 46(9), DOI: 10.1016/j.gastrohep.2023.09.001

Authors: Delgado-Guillena, Pedro; Velamazan-Sandalinas, Raul; Sanchez, Javier Jimenez; Fuentes-Valenzuela, Esteban; Garcia-Morales, Natalia; Cuatrecasas, Miriam; Jimeno, Mireya; Moreira, Leticia; Albeniz, Eduardo

Affiliations

Complejo Hosp Univ Alvaro, Inst Invest Sanitaria Galicia Sur, Dept Gastroenterol, Vigo, Spain - Author
Department of Gastroenterology, Complejo Hospitalario Universitario de Vigo, Instituto de Investigación Sanitaria Galicia Sur, Vigo, España. - Author
Department of Gastroenterology, Hospital Clinic of Barcelona. Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD). IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, España. - Author
Department of Gastroenterology, Hospital Universitario de Navarra (HUN). Navarrabiomed, Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain. - Author
Department of Gastroenterology, Hospital Universitario Río Hortega, Valladolid, Spain. - Author
Department of Gastroenterology, Hospital Universitario Vall d'Hebrón, Instituto de Investigacción Vall d'Hebrón (VHIR), Barcelona, Spain. - Author
Department of Gastroenterology, Hospital Vega Baja, Orihuela, Spain. - Author
Department of Gastroenterology. Hospital de Mérida, Badajoz, Spain. Electronic address: pgdg20@gmail.com. - Author
Department of Pathology, CDB. Hospital Clínic of Barcelona. Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD). IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, España. - Author
Department of Pathology, Hospital Germans Trias i Pujol, Badalona, Spain. - Author
Hosp Clin Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, IDIBAPS Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain - Author
Hosp Clin Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Dept Pathol,CDB, Barcelona, Spain - Author
Hosp Germans Trias I Pujol, Dept Pathol, Badalona, Spain - Author
Hosp Merida, Dept Gastroenterol, Badajoz, Spain - Author
Hosp Univ Rio Hortega, Dept Gastroenterol, Valladolid, Spain - Author
Hosp Univ Vall Hebron, Dept Gastroenterol, Inst Invest Vall Hebron VHIR, Barcelona, Spain - Author
Hosp Vega Baja, Dept Gastroenterol, Orihuela, Spain - Author
Univ Barcelona, Fac Med & Ciencies Salut, Barcelona, Spain - Author
Univ Publ Navarra UPNA, Navarrabiomed, Hosp Univ Navarra HUN, Dept Gastroenterol, Pamplona, Spain - Author
See more

Abstract

[No abstract available]

Keywords

classificationdiagnosisintestinal metaplasialesionsmanagementolgasocietystomachsydney systemArticleAtrophic gastritisCancer classificationCancer epidemiologyCancer riskCancer stagingChronic atrophic gastritisClinical practiceComplicationConsensus developmentDisease associationDisease classificationDisease courseEndoscopyGastric cancerGastric mucosaGastritisGastritis, atrophicGastrointestinal endoscopyGastrointestinal metastasisHelicobacter infectionHelicobacter infectionsHelicobacter pyloriHumanHumansMedical historyPractice guidelinePrecancerRiskRisk assessmentStomach cancerStomach mucosaStomach neoplasmsStomach tumor

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Gastroenterologia Y Hepatologia, and although the journal is classified in the quartile Q3 (Agencia WoS (JCR)), its regional focus and specialization in Gastroenterology & Hepatology, give it significant recognition in a specific niche of scientific knowledge at an international level.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 3.85, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions Aug 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-08-07, the following number of citations:

  • WoS: 4
  • Scopus: 2
  • Europe PMC: 3

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-08-07:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 9.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 13 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 0.5.
  • The number of mentions on the social network X (formerly Twitter): 1 (Altmetric).